Detection and sequence analysis of tryptic peptides by microcolumn liquid chromatography-tandem mass spectrometry using an electrospray interface
✍ Scribed by Mark Hail; Sydell Lewis; Ian Jardine; Jinping Liu; Milos Novotny
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 501 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1040-7685
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Fused‐silica packed LC capillaries were interfaced with a triple quadrupole mass spectrometer through the electrospray ionization device. The coupling of these powerful techniques is suitable for structural characterization of constituents of peptide maps generated at high sensitivity. Sequence determinations appear possible at the femtomole level following this approach.
📜 SIMILAR VOLUMES
Linalool, nerol, geraniol, citronellol and a-terpineol were phosphorylated and the products purified by adsorption chromatography on XAD-2. High performance liquid chromatography-tandem mass spectrometry (LC-MSMS) analysis using the electrospray ionization technique (ESI) revealed the occurrence of
An on-line method has been developed for the derivatization and coupled liquid chromatography (LC)/electrospray ionization (ESI) MS analysis of peptides at the femtomol level. Peptides are reacted with N-succinimidyl-2(3-pyridyl)acetate (SPA) in buffered aqueous medium at pH 7 following loading on a
Analytical techniques for the detection of small amounts of explosives (in the picogram range) are now involved in various application. Some of them concern soil, water and air monitoring in order to face environmental problems related to improper handling procedures either in stocking or in wasting
Because of the lack of a UV chromophore and their much smaller abundances in comparison with the major component, the minor components in erythromycin estolate preparations are difficult to analyze by high performance liquid chromatography ultraviolet (HPLC-UV). Tentative assignment of the major and
## Abstract Eflucimibe (F 12511) is a new and promising acyl‐coenzyme A cholesterol __O__‐acyl‐transferase (ACAT) inhibitor, developed at the Pierre Fabre Research Center for the treatment of atherosclerosis. Owing to the synthetic pathway, residual impurities may be present (at very low levels) in